Health Trials

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

ConditionPrimary Immune Thrombocytopenia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGruppo Italiano Malattie EMatologiche dell'Adulto

About this trial

Retrospective data collection on ITP patients who underwent splenectomy from 01/01/2010 to 12/31/2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Eligibility criteria

Qualifiers

Patients aged ≥ 18 years

Patients with primary ITP according to international criteria [2], who underwent to splenectomy from 01/01/2010 to 12/31/2022.

Obtaining Informed Consent.

Disqualifiers

none

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Gruppo Italiano Malattie EMatologiche dell'Adulto

Lead sponsor

Source ClinicalTrials.gov